Literature DB >> 28621806

Inequalities in uptake of prenatal screening according to ethnicity and socio-economic status in the four largest cities of the Netherlands (2011-2013).

Anke G Posthumus1, Ingrid A Peters1,2, Gerard J Borsboom3, Maarten F C M Knapen1,2, Gouke J Bonsel4.   

Abstract

OBJECTIVES: In the Netherlands, all women are claimed to have equal access to prenatal screening (PS). Prior research demonstrated substantial inequalities in PS uptake associated with socioeconomic status (SES) and ethnic background. The suggested pathway was a lack of intention to participate in PS among these subgroups. We studied the background of inequalities in PS participation, challenging intention heterogeneity as the single explanation.
METHODS: Multivariable logistic regression analyses of the national PS registry, focusing on the four largest cities in the Netherlands (n = 4578, years 2011-2013), stratified by SES. OUTCOME MEASURES: (1) any uptake of PS (yes/no) and (2) uptake (one/two tests) for women who intended to participate in two tests. Determinants included intention, ethnicity, practice, and age.
RESULTS: Of non-Western women, 85.7% were screened versus 89.7% of Western women. Intention was an important explanatory factor in all models. However, after correction for intention, ethnicity remained a significant determinant for differences in uptake. Ethnicity and SES also interacted, indicating that non-Western women in low SES areas had the lowest uptake (corrected for intention). CONCLUSIONS FOR PRACTICE: Socioeconomic status and ethnicity related inequalities in PS uptake are only partially explained by intention heterogeneity; other pathways, in particular provider-related determinants, may play a role.
© 2017 John Wiley & Sons, Ltd. © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28621806     DOI: 10.1002/pd.5089

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

1.  Utilisation of supplementary prenatal screening and diagnostics in Germany: cross-sectional study using data from the KUNO Kids Health Study.

Authors:  Johanna Mayer; Susanne Brandstetter; Christina Tischer; Birgit Seelbach-Göbel; Sara Fill Malfertheiner; Michael Melter; Michael Kabesch; Christian Apfelbacher
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-24       Impact factor: 3.105

2.  Routinization of prenatal screening with the non-invasive prenatal test: pregnant women's perspectives.

Authors:  Karuna R M van der Meij; Annabel Njio; Linda Martin; Janneke T Gitsels-van der Wal; Mireille N Bekker; Elsbeth H van Vliet-Lachotzki; A Jeanine E M van der Ven; Adriana Kater-Kuipers; Danielle R M Timmermans; Erik A Sistermans; Robert-Jan H Galjaard; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2021-08-13       Impact factor: 5.351

3.  Complications and Healthcare Consumption of Pregnant Women with a Migrant Background: Could There be an Association with Psychological Distress?

Authors:  Hanna M Heller; Annemijn V R de Vries; Adriaan W Hoogendoorn; Fedde Scheele; Willem J Kop; Christianne J M de Groot; Adriaan Honig; Birit F P Broekman
Journal:  Matern Child Health J       Date:  2022-06-02

4.  Satisfaction with obstetric care in a population of low-educated native Dutch and non-western minority women. Focus group research.

Authors:  Ingrid A Peters; Anke G Posthumus; Eric A P Steegers; Semiha Denktaş
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

5.  Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access.

Authors:  Robert-Jan H Galjaard; Inez D de Beaufort; Eline M Bunnik; Adriana Kater-Kuipers
Journal:  J Med Ethics       Date:  2019-09-16       Impact factor: 2.903

6.  Non-invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods.

Authors:  Karuna R M van der Meij; Caroline Kooij; Mireille N Bekker; Robert-Jan H Galjaard; Lidewij Henneman
Journal:  Prenat Diagn       Date:  2021-09-14       Impact factor: 3.242

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.